Professor Denis Xavier
St John's Medical College Hospital, Bangalore (India)
Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin: insights from the ARISTOTLE trial
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Anticoagulation in atrial fibrillation III
ESC 365 is supported by
